Advertisement
News
Subscribe to Surgical Products Magazine News
View Sample

FREE Email Newsletter

Surgical Products Daily

Cancer Patients Prefer Risky Treatments

April 10, 2012 6:48 am | Comments

A new analysis provides a closer look at how much cancer patients value hope — with important implications for how insurers value treatment, particularly in end-of-life care. The analysis led by Darius Lakdawalla, director of research at the Schaeffer Center at USC and associate professor in the USC Price School of Public Policy, surveyed 150 cancer patients currently undergoing treatment, and is part of a special issue on cancer spending from the journal Health Affairs .

Protein Identification Could Help Predict Pulmonary Metastases In Breast Cancer Patients

April 10, 2012 6:38 am | Comments

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that the modulation of the levels of this protein could be a new therapeutic strategy to prevent lung metastases.

Anesthesiologists Continue Supervision Battle

April 10, 2012 6:29 am | Comments

The California Society of Anesthesiologists has, along with its partner, the California Medical Association, decided to request a review by the California Supreme Court in CSA and CMA v. Schwarzenegger. This course of action follows the March 15, 2012 decision to affirm the December 27, 2010 decision of the Superior Court that California law does not require physician supervision of nurse anesthetists.

Advertisement

Recovery From Propofol Anesthesia Can Be Improved By Stimulant

April 9, 2012 8:44 am | Comments

The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.

TOPICS:

New Staging Classifications For Pancreatic Tumor Surgeries

April 9, 2012 8:06 am | Comments

Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery. The results of their study were published in a recent issue of the Annals of Surgery .

Complications After Oesophageal Surgery Can Cause Lasting Problems

April 9, 2012 7:38 am | Comments

Oesophageal cancer is a very serious form of cancer that, if not fatal, requires extensive surgery. A new study from Karolinska Institutet shows that when serious complications arise after surgery for oesophageal cancer, many patients suffer other health problems, such as breathlessness, fatigue, insomnia and eating problems, for up to five years afterwards.

Covidien Joins Healthcare Plastics Recycling Council

April 9, 2012 6:59 am | Comments

The Healthcare Plastics Recycling Council has welcomed Covidien as its newest member, bringing the total council membership to 12 companies. “As we seek to improve the recyclability of plastic products in healthcare, their insights will be instrumental," stated Tod Christenson, Director of HPRC.

Surgical Management Has Little Effect On Neurodevelopmental Outcomes

April 6, 2012 8:11 am | Comments

/PRNewswire/ -- In the largest multicenter clinical trial of children undergoing early-stage surgery for single-ventricle heart defects, differences in intraoperative management did not significantly affect neurodevelopmental outcomes at 14 months of age. Instead, the strongest influences were innate patient characteristics and general medical morbidity during the child's first year of life.

Advertisement

Trial For Compartment Syndrome Focused On Wounded Warriors Approved

April 6, 2012 7:57 am | Comments

/PRNewswire/ -- Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01T technology in the treatment of Compartment Syndrome.

Manufacturer Sued For Death Arising From Surgical Robot

April 6, 2012 7:46 am | Comments

/PRNewswire/ -- The father of his deceased 24 year old daughter has commenced a lawsuit in New York against Intuitive Surgery, Inc., the maker of the da Vinci surgical robot, alleging that the device caused her death. In his complaint, filed by the firm of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP of New York City, Gilmore McCalla asserts that when his daughter was having a hysterectomy in a Bronx hospital in August 2010, the robot caused burns to an artery and her intestines, which led to her death two weeks later.

Hope For Baby Born With Stunted Intestines

April 6, 2012 7:38 am | by Alison Mutler | Comments

BUCHAREST, Romania — Baby Andrei has confounded doctors just by being alive: The tiny boy with twig-thin limbs was given just days to live when he was born with almost no intestines — eight months ago. Now there's hope for another miracle. Harvard University and hospitals in Boston have offered to help Andrei get a complicated intestine transplant that isn't performed on babies in Europe, the Romanian pediatrician in charge of the baby's care said Thursday.

Positive Results For Instrument Sterilization Tests

April 4, 2012 9:03 am | Comments

/PRNewswire/ -- BioNeutral Group announced the positive results of a series of tests performed by Dr. Philip Tierno with respect to the use of Ygiene 206 and the sterilization of surgical instruments. Surgical instruments and surgical material were contaminated with difficult to kill organisms at levels up to 10,000x.

Allograft Exhibits Ideal Properties For Bone Regeneration

April 4, 2012 7:53 am | Comments

/PRNewswire/ -- Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces that a peer review article in Dove Press Journal has determined its OsteoSponge allograft exhibits ideal properties for bone regeneration, similar to those of autografts (graft of patient's own bone) with the distinct advantage over autografts, in that there is no risk of complications at the harvest site or donor pain postoperatively.

TOPICS:

Covidien Prevails In Patent Action

April 4, 2012 7:36 am | Comments

(BUSINESS WIRE)--Apr 4, 2012-- Covidien,a leading global provider of healthcare products, announced that it has prevailed against Applied Medical Resources Corp. in a patent action before the U.S. District Court, Central District of California. In granting Covidien's motion of summary judgment, the District Court ruled that Covidien's trocar products do not infringe Applied Medical's patent.

Researchers Present Data On RF Surgical Technology

April 4, 2012 7:29 am | Comments

(BUSINESS WIRE)--RF Surgical Systems, Inc. has announced the presentation of positive data from the largest-ever prospective, multi-institution study of the detection and prevention of retained surgical items (RSI) for improving patient safety and increasing staff confidence during surgical procedures.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading